KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ionis Pharmaceuticals (IONS) Non Operating Investment Income (2019 - 2025)

Historic Non Operating Investment Income for Ionis Pharmaceuticals (IONS) over the last 14 years, with Q3 2025 value amounting to $29.9 million.

  • Ionis Pharmaceuticals' Non Operating Investment Income rose 330250.28% to $29.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 million, marking a year-over-year increase of 152406.64%. This contributed to the annual value of -$2.9 million for FY2024, which is 5094.04% down from last year.
  • As of Q3 2025, Ionis Pharmaceuticals' Non Operating Investment Income stood at $29.9 million, which was up 330250.28% from -$18.3 million recorded in Q2 2025.
  • Ionis Pharmaceuticals' 5-year Non Operating Investment Income high stood at $29.9 million for Q3 2025, and its period low was -$18.3 million during Q2 2025.
  • For the 5-year period, Ionis Pharmaceuticals' Non Operating Investment Income averaged around $410388.9, with its median value being $278500.0 (2023).
  • As far as peak fluctuations go, Ionis Pharmaceuticals' Non Operating Investment Income tumbled by 149503.11% in 2024, and later surged by 330250.28% in 2025.
  • Quarter analysis of 5 years shows Ionis Pharmaceuticals' Non Operating Investment Income stood at $5.2 million in 2021, then plummeted by 37.08% to $3.3 million in 2022, then crashed by 104.9% to -$161000.0 in 2023, then crashed by 1495.03% to -$2.6 million in 2024, then surged by 1264.64% to $29.9 million in 2025.
  • Its Non Operating Investment Income was $29.9 million in Q3 2025, compared to -$18.3 million in Q2 2025 and -$2.2 million in Q1 2025.